AT&S Technology Eases Burden on Healthcare System Through Individualized Medicine


Reading time ( words)

Body temperature can be a valuable indication for doctors when diagnosing diseases. However, selective measurements may sometimes result in misleading information. The start-up SteadySense addresses this problem with SteadyTemp, a smart patch that allows medical professionals to track the development accurately over several days. As a result, infectious diseases such as influenza or corona can be identified early and the effect of antipyretic medication can be monitored in real time.

In a clinical setting, SteadyTemp allows easy and automated temperature readings so that repeated thermometer measurements are no longer necessary and the workload of the nursing staff is reduced. This brings valuable relief for hospitals and retirement homes, in particular during the cold season. Moreover, people prone to disease can use the patch at home in order to identify potential problems early. The temperature curves can be easily transmitted to the family doctor as a PDF file via the app.

Individual care

SteadyTemp is available for purchase in pharmacies and the SteadySense online shop. In Europe, the product has already been approved for clinical use; the approval process of the US regulatory authority FDA is currently ongoing. This marks a great success for medical technology made in Austria: The flexible sensor electronics at the heart of the smart patch is made by AT&S. “Now that the femSense ovulation tracker is already available in the US market, we are currently taking the final steps to also receive the FDA approval for our STEADYTEMP product. This will open up a huge market for which we need a flexible and reliable partner like AT&S to be able to respond quickly to fluctuations in demand,” says Peter Gasteiner, co-founder and COO of SteadySense.

Researchers of the Medical University of Graz, who supported the clinical approval process for SteadyTemp, consider the new development a big step toward individualised medicine for private and clinical settings. “Healthcare systems have increasingly come under pressure over the past years, not just due to the pandemic. AT&S is proud to offer a solution in cooperation with SteadyTemp which can ease the burden on hospitals and nursing staff through targeted monitoring of vulnerable patients,” says Gerald Reischl, VP Corporate Communications at AT&S.

Share




Suggested Items

Jan Pedersen: Dieter Bergman IPC Fellowship Award Recipient

03/10/2021 | Patty Goldman, I-Connect007
Patty Goldman speaks with Jan Pedersen of Elmatica, Dieter Bergman IPC Fellowship Award recipient, about his extensive involvement with IPC on many committees developing standards, especially the automotive and medical addendums to IPC-6012 and 6013.

IPC Europe Shares Technical Education and Standards Awareness

04/22/2020 | Pete Starkey, I-Connect007
Against a background of COVID-19 uncertainty and unprecedented challenges, but recognizing the vital importance of continuing to educate engineers and share the knowledge and skills required to manufacture boards and assemblies of the highest yields and reliability, the IPC Europe team hosted a technical webinar for the European electronics industry, featuring the expertise of two of I-Connect007’s regular columnists: Mike Carano and Jan Pedersen. Pete Starkey provides an overview.

American Standard Circuits' Ken Moffat on Flex and Rigid-flex Business

04/22/2019 | Patty Goldman, I-Connect007
Ken Moffat is the director of business development at American Standard Circuits, where covers a fairly broad territory from his base in Toronto throughout Canada and parts of the U.S. from east to west. In an interview with I-Connect007 at the recent West Penn SMTA Expo, Ken talks about the state of the flex and rigid-flex industry.



Copyright © 2023 I-Connect007 | IPC Publishing Group Inc. All rights reserved.